This year’s event will be held on September 27 at the Chelsea Hotel Toronto, 33 Gerrard St. W.
The 2019 Liver Research Day and Nurse & Allied Health Hepatology Update will be held on September 26, 2019 at the Chelsea Hotel Toronto, 33 Gerrard St. W.
Sign up to our mailing list to receive important alerts on the upcoming event!
This event is accredited by both the RCPSC and CFPC.
A message from the chairperson, Dr. Hemant Shah.
Hepatology Update is the premiere CME event for Ontario’s practicing health care providers. The goal of the day is to provide sensible, relevant and accurate updates on liver disease management that each attendee can use for the benefit of their patients. By attending this conference, you will have the opportunity to hear from national and international experts in the field in an interactive and thought-provoking forum.
See a previous year’s speaker, Dr. David Wong:
Please see our tentative agenda below:
Hepatology Update 2019
|September 27, 2019|
|7:30 am||8:15 am||BREAKFAST|
|8:15 am||8:25 am||Welcome||Hemant Shah|
|Session 1 – Fatty Liver Across the Spectrum|
|Fatty liver is a major public health problem, in the clinic and in the community. This session will explore how to identify fatty liver in the office setting, and how to manage the liver disease and the metabolic disease. Some patients will progress to require liver transplant, and we will explore how referring doctors can prepare these patients for that, and what is done during transplant to maximize outcomes.|
|8:25 am||8:30 am||Introduction||Morven Cunningham|
|8:30 am||8:50 am||What the Referring Doctor Should Know about Liver Transplant for NASH/Obesity||Julie Heimbach|
|8:50 am||9:10 am||Identifying NASH in the Community Clinic and Monitoring Progression||Keyur Patel|
|9:10 am||9:30 am||Therapies for NASH: Today and Tomorrow||Gideon Hirschfield|
|9:30 am||9:50 am||The Medical Management of Obesity||Satya Dash|
|9:50 am||10:20 am||Panel Discussion|
|10:25 am||10:40 am||BREAK|
|Session 2 – Quality Care for Cirrhosis|
|The management of cirrhosis poses challenges to providers and the system alike. In this session, we will explore strategies that can maximize the outcomes of patients with cirrhosis and prevent the cycle of continued hospitalizations. We will also introduce some concepts of palliative care that will benefit the person with end-stage liver disease.|
|10:45 am||10:50 am||Introduction||David Wong/ Fernanda Onofrio|
|10:50 am||11:20 am||How to Maximize Cirrhosis QOL and Minimize Readmissions||Elliot Tapper|
|11:20 am||11:30 am||Two Effective Interventions for Hepatic Encephalopathy||Elizabeth Lee|
|11:30 am||11:40 am||Two tips for Optimizing Nutrition in Patients with Liver Disease||Brooke Stewart|
|11:40 am||12:00 pm||Palliating End Stage Liver Disease||Ebru Kaya|
|12:00 pm||12:30 pm||Panel Discussion|
|12:30 pm||1:05 pm||LUNCH|
|Session 3 – Voices of Patients|
|In this session, we will hear the stories and advice of people with lived experience. They will inspire us to continue to provide the best possible care.|
|1:05 pm||1:10 pm||Introduction||Aliya Gulamhusein|
|1:10 pm||1:20 pm||Living with Liver Disease||Christine Maxwell|
|1:20 pm||1:30 pm||My Living Donor Experience||Heather Badenoch|
|1:30 pm||1:40 pm||My Transplant Experience||Kristian Stephens|
|Session 4 – Viral Hepatits – New Frontiers|
|Viral hepatitis remains common and under diagnosed. As we continue to aim high with a goal towards elimination of Hepatitis C and better management of Hepatitis B, this session will explore how we are striving to do that. The special issue of virus management during pregnancy will be discussed in detail.|
|1:40 pm||1:45 pm||Introduction||Scott Fung/Maryam Moini|
|1:45 pm||2:05 pm||Managing the Pregnant Patient with Hepatitis B or C||Colina Yim|
|2:05 pm||2:35 pm||Simplifying Hepatitis C Treatment, and a Blueprint for Elimination||Jordan Feld|
|2:35 pm||2:55 pm||Hepatitis B: Can we cure it and if so, how?||Harry Janssen|
|2:55 pm||3:30 pm||Panel Discussion|
|3:30 pm||3:40 pm||Closing Remarks||Hemant Shah|